Profile
Substance use treatment; Detoxification; Outpatient; Outpatient detoxification; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment; Buprenorphine used in Treatment; Naltrexone used in Treatment; This facility administers/prescribes medication for alcohol use disorder; Other contracted prescribing entity; Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Acamprosate (CampralĀ®); Disulfiram; Buprenorphine with naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Motivational interviewing; Telemedicine/telehealth therapy; Tribal government; Federal, or any government funding for substance use treatment programs; IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants; Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Drug or alcohol urine screening; HIV testing; STD testing; TB screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV); Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Self-help groups; Mentoring/peer support; Substance use disorder education; Individual counseling; Group counseling; Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination; Smoking not permitted; Adults; Female; Male; Vaping not permitted; Mental health services